Inventor · disambiguated record
Xinyuan Wu
Also filed as: WU XINYUAN · WU XINYUAN EDWARD
21 granted patents·16 pending applications·48 citations·filing 2005–2024
93Inventor score
Files withBOEHRINGER INGELHEIM INT5ALANTOS PHARM HOLDING4ALANTOS PHARMACEUTICALS INC4HYDRA BIOSCIENCES INC4WU XINYUAN4
Top patents by PatentIndex Score
37 records- 0194US10766888B1HMOX1 inducersMITOBRIDGE INC·Filed 2020·Granted Sep 8, 2020·16 cites·11 claims
- 0287USRE49699EInhibitors of TRPC6BOEHRINGER INGELHEIM INT·Filed 2021·Granted Oct 17, 2023·1 cites·40 claims
- 0385US8530487B1Compounds useful for treating disorders related to TRPA1WU XINYUAN·Filed 2010·Granted Sep 10, 2013·4 cites·11 claims
- 0484US10889568B2Inhibitors of TRPC6BOEHRINGER INGELHEIM INT·Filed 2018·Granted Jan 12, 2021·3 cites·28 claims
- 0583US10800757B2Inhibitors of TRPC6BOEHRINGER INGELHEIM INT·Filed 2018·Granted Oct 13, 2020·3 cites·28 claims
- 0682US8952023B1Compounds useful for treating injuries from warfare agentsWU XINYUAN·Filed 2013·Granted Feb 10, 2015·2 cites·10 claims
- 0781US10221177B2Inhibiting the transient receptor potential A1 ion channelHYDRA BIOSCIENCES INC·Filed 2015·Granted Mar 5, 2019·3 cites·22 claims
- 0880US9193729B2Inhibiting transient receptor potential ion channel TRPA1CUBIST PHARM INC·Filed 2013·Granted Nov 24, 2015·6 cites·11 claims
- 0979US11807621B2Compounds and compositions for use in treating skin disordersKAMARI PHARMA LTD·Filed 2021·Granted Nov 7, 2023·1 cites·27 claims
- 1078US12043607B2HDAC inhibitors and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2022·Granted Jul 23, 2024·0 cites·34 claims
- 1176US12071433B2HMOX1 inducersASTELLAS ENG SMALL MOLECULES US INCORPORATED·Filed 2023·Granted Aug 27, 2024·0 cites·11 claims
- 1276US10519158B2Inhibiting the transient receptor potential A1 ion channelLILLY CO ELI·Filed 2018·Granted Dec 31, 2019·1 cites·20 claims
- 1375US2025136570A1Hdac inhibitors and therapeutic use thereofTANGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1473US11485740B2Inhibitors of TRPC6BOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 1, 2022·1 cites·20 claims
- 1573US2024409533A1Hmox1 inducersASTELLAS ENG SMALL MOLECULES US INCORPORATED·Filed 2024·Application pending·0 cites
- 1672US8835441B2Heterobicyclic metalloprotease inhibitorsSTEENECK CHRISTOPH·Filed 2011·Granted Sep 16, 2014·3 cites·10 claims
- 1770US7713966B2Heterobicyclic metalloprotease inhibitorsALANTOS PHARM HOLDING·Filed 2007·Granted May 11, 2010·1 cites·12 claims
- 1869US12435061B2Compounds and compositions for use in treating skin disordersKAMARI PHARMA LTD·Filed 2023·Granted Oct 7, 2025·0 cites·44 claims
- 1969US10428072B2Inhibiting the transient receptor potential A1 ion channelLILLY CO ELI·Filed 2018·Granted Oct 1, 2019·1 cites·58 claims
- 2069US7795245B2Heterobicyclic metalloprotease inhibitorsATLANTOS PHARMACEUTICALS HOLDI·Filed 2007·Granted Sep 14, 2010·2 cites·15 claims
- 2168US2015352115A1Compounds useful for treating injuries from warfare agentsWU XINYUAN·Filed 2014·Application pending·0 cites
- 2268US2021163449A1Inhibitors of trpc6BOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2364US9012465B1Compounds useful for treating disorders related to TRPA1WU XINYUAN·Filed 2013·Granted Apr 21, 2015·0 cites·2 claims
- 2463US9505756B2Compounds useful for treating disorders related to TRPA1HYDRA BIOSCIENCES INC·Filed 2015·Granted Nov 29, 2016·0 cites·20 claims
- 2561US2009312312A1Heterobicyclic Metalloprotease InhibitorsALANTOS PHARM HOLDING·Filed 2009·Application pending·0 cites
- 2661US2018051020A1Compounds useful for treating disorders related to trpa1HYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2756US2007155738A1Heterobicyclic metalloprotease inhibitorsALANTOS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2853US11161849B2Inhibiting the transient receptor potential al ion channelLILLY CO ELI·Filed 2019·Granted Nov 2, 2021·0 cites·14 claims
- 2953US2023025807A1Cd38 inhibitorsMITOBRIDGE INC·Filed 2020·Application pending·0 cites
- 3052US2008161300A1Heterobicyclic metalloprotease inhibitorsALANTOS PHARM HOLDING·Filed 2007·Application pending·0 cites
- 3146US2007155737A1Heterobicyclic metalloprotease inhibitorsALANTOS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3245US2006293345A1Heterobicyclic metalloprotease inhibitorsSTEENECK CHRISTOPH·Filed 2006·Application pending·0 cites
- 3343US2007155739A1Substituted bis-amide metalloprotease inhibitorsALANTOS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3443US2008021024A1Metalloprotease inhibitorsALANTOS PHARM HOLDING·Filed 2007·Application pending·0 cites
- 3541US2008176870A1Heterobicyclic metalloprotease inhibitorsNOLTE BERT·Filed 2007·Application pending·0 cites
- 3639US2006173183A1Multicyclic bis-amide MMP inhibitorsALANTOS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3736US2017050966A1Inhibiting the transient receptor potential a1 ion channelHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xinyuan Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →